Johnson Pope Advises PharmaLink on Private Equity Growth Investment

Johnson Pope Bokor Ruppel & Burns, LLP is pleased to announce its role as legal counsel to PharmaLink, LLC, a leading pharmaceutical reverse logistics and returns management company, in its recent growth investment by WestView Capital Partners. WestView Capital Partners is a Boston-based growth equity firm managing $2.7 billion in capital, with a primary focus on middle-market growth companies. 

PharmaLink is optimistic about the future following the investment from WestView Capital Partners, which was represented by Latham & Watkins LLP. PharmaLink recently expanded its flagship operations center, more than doubling its processing capacity. With WestView’s support, PharmaLink “will continue to deliver premium reverse logistics solutions to their clients,” said Thierry Beckers, President & CEO of PharmaLink. 

The transaction was led by Adam Kravatz, a Florida-based M&A attorney with deep experience in structuring complex corporate transactions, particularly within the healthcare industry. He was supported by corporate partners Mike Cronin, Patrick Traber, and associate Tyler Willis. 

PharmaLink’s transaction involved significant regulatory navigation due to the company’s role in pharmaceutical distribution. Johnson Pope provided multidisciplinary legal support, including: 

• Corporate M&A law 
• Healthcare regulatory compliance 
• Employment law 
• Intellectual property 
• Tax structuring 

Thanks to proactive coordination and thorough issue-spotting, the deal closed smoothly without delays or complications. 

This transaction highlights Johnson Pope’s strength in middle-market M&A transactions in highly regulated industries, particularly those involving private equity growth investments in healthcare and pharmaceutical companies. 

To learn more about our corporate and healthcare M&A services in Florida, or to speak with lead deal attorney Adam Kravatz, please contact us.